Search

everythinglearnresearchcommunity

for

Search:↓

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Treating stubborn hair loss involves both medical and emotional support options.

Hyaluronic acid injections can improve mouth opening and quality of life in scleroderma patients.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

New alopecia treatments aim for better results and fewer side effects.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Topical calcipotriol successfully treated hair loss in three patients with Alopecia Totalis.

Tofacitinib may help treat severe hair loss, but more research is needed.

Minoxidil effectively treats hair loss, but use cautiously and monitor side effects.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Adolescents with severe alopecia incur significantly higher healthcare costs.

Alopecia areata in US adolescents leads to significant healthcare costs and usage.

Minoxidil was more effective than laser therapy for hair loss, and the report also highlighted the need for more research on PRP for a different hair loss condition, the impact of social media on alopecia views, and a warning on turmeric causing nail discoloration.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

The model and estimator can predict drug exposure in kidney transplant patients well.